Teleflex Incorporated (FRA:TBH)
Germany · Delayed Price · Currency is EUR | Market Cap | 4.29B |
| Revenue (ttm) | 2.73B |
| Net Income (ttm) | -280.48M |
| Shares Out | n/a |
| EPS (ttm) | -6.21 |
| PE Ratio | n/a |
| Forward PE | 7.60 |
| Dividend | 1.20 (1.26%) |
| Ex-Dividend Date | Nov 14, 2025 |
| Volume | 79 |
| Average Volume | 4 |
| Open | 93.50 |
| Previous Close | 107.00 |
| Day's Range | 93.50 - 95.50 |
| 52-Week Range | 88.00 - 174.00 |
| Beta | n/a |
| RSI | 35.62 |
| Earnings Date | Feb 26, 2026 |
About Teleflex
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, the measurement of blood pressure, and the collection of blood samples. The company also offers interventional products, including various co... [Read more]
Financial Performance
In 2024, Teleflex's revenue was $3.05 billion, an increase of 2.45% compared to the previous year's $2.97 billion. Earnings were $69.68 million, a decrease of -80.45%.
Financial numbers in USD Financial StatementsNews
Teleflex names new interim CEO
Teleflex (TFX) Appoints Stuart Randle as Interim CEO Amid Leadership Changes
Teleflex (TFX) Appoints Stuart Randle as Interim CEO Amid Leadership Changes
Teleflex Announces Leadership Transition
Stuart Randle Appointed Interim President and CEO Board Initiates Search for Permanent CEO Dr. Stephen Klasko Appointed Chairman of the Board Company Provides Update on Preliminary Full Year 2025 Reve...
Teleflex Breaks Above 200-Day Moving Average - Bullish for TFX
In trading on Monday, shares of Teleflex Incorporated (Symbol: TFX) crossed above their 200 day moving average of $123.57, changing hands as high as $125.18 per share. Teleflex Incorporated shares are...
Teleflex (TFX) Analyst Ratings Update: Truist Securities Revises Price Target | TFX Stock News
Teleflex (TFX) Analyst Ratings Update: Truist Securities Revises Price Target | TFX Stock News
Should You Retain Teleflex Stock in Your Portfolio Now?
TFX's UroLift expansion and Barrigel traction support long-term growth, but high debt and FX headwinds keep the stock under pressure.
This ETF Holds Stocks Insiders Want to Own
A look at the weighted underlying holdings of the Vanguard Health Care ETF (VHT) shows an impressive 17.3% of holdings on a weighted basis have experienced insider buying within the past six months. T...
Teleflex: Selling, But How Much?
Teleflex (TFX) Receives Updated Analyst Rating from Wells Fargo | TFX Stock News
Teleflex (TFX) Receives Updated Analyst Rating from Wells Fargo | TFX Stock News
TFX Crosses Above Average Analyst Target
In recent trading, shares of Teleflex Incorporated (Symbol: TFX) have crossed above the average analyst 12-month target price of $125.50, changing hands for $131.25/share. When a stock reaches the tar...
Teleflex Sells Acute Care, Interventional Urology, OEM Businesses For $2.03Bln
(RTTNews) - Teleflex Inc. (TFX), a global provider of medical technologies, has entered into definitive agreements to divest its Acute Care, Interventional Urology, and OEM businesses for a combined t...
Teleflex (TFX) Shares Cross Above 200 DMA
In trading on Tuesday, shares of Teleflex Incorporated (Symbol: TFX) crossed above their 200 day moving average of $125.21, changing hands as high as $136.95 per share. Teleflex Incorporated shares ar...
Teleflex (TFX) Sees Notable Increase in Stock Value
Teleflex (TFX) Sees Notable Increase in Stock Value
Teleflex (TFX) to Sell Businesses for $2.03 Billion, Focus on Core Operations
Teleflex (TFX) to Sell Businesses for $2.03 Billion, Focus on Core Operations
Teleflex (TFX) to Divest Units for $2.03 Billion in Cash
Teleflex (TFX) to Divest Units for $2.03 Billion in Cash
Teleflex To Divest Acute Care, Interventional Urology, OEM Businesses For $2.03 Bln
(RTTNews) - Teleflex Inc. (TFX), a medical technologies provider, Tuesday announced that it has agreed to sell its Acute Care, Interventional Urology to Intersurgical Ltd and OEM businesses to Montagu...
Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction
NEW YORK--(BUSINESS WIRE)--Montagu and Kohlberg, two leading middle-market private equity firms, today announced that they have entered into a definitive agreement to acquire Teleflex Medical OEM (the...
Teleflex to sell acute care, interventional urology, OEM units for $2.03B
Teleflex sells key units for $2B, refocusing on core medical tech and launching $1B share buyback.
Teleflex to sell three of its businesses for $2.03 billion
Medical device maker Teleflex said on Tuesday it will sell three of its business units for a total of $2.03 billion in cash.
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
Board of Directors authorizes new $1 billion share repurchase program Board of Directors authorizes new $1 billion share repurchase program
Teleflex Incorporated (TFX) Presents at Jefferies London Healthcare Conference 2025 Transcript
Don't Overlook Teleflex (TFX) International Revenue Trends While Assessing the Stock
Explore Teleflex's (TFX) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Teleflex to Present at the Jefferies Global Healthcare Conference in London
WAYNE, Pa., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 202...